The studies investigating an association between HRT and breast cancer risk in BRCA1/2 mutation carriers after RRBSO mostly did not find an adverse effect, either (Rebbeck et al. 2005; Kotsopoulos et al. 2018; Marchetti et al. 2018). This evidence concerns the gene BRCA1 and breast cancer.